UPM-Kymmene

Healthy Q3; there were some setbacks however

30/10/24 -"While UPM’s Q3 results were healthy – and largely Pulp-driven – they fell short of the market’s expectations. Perhaps the biggest disappointment was the group-level demand recovery ..."

PDF page sample
Pages
52
Language
English
Published on
30/10/24
Download
You may also be interested by these reports :
26/03/25
Paper & Packaging has been on a downward slope since April 2022. It seems to be intent on going lower even though there is no new news to crash ...
18/03/25
Sustaining its operating recovery momentum – evident since early 2024, MMK ended the year with strong Q4 results. There were varying positives across ...
24/02/25
Although market sentiment remained brutal last year, a noticeable recovery in Mayr-Melnhof Karton’s (MMK) share price has been evident since late ...
12/02/25
While Stora’s Q4 results came ahead of street expectations and there was a noticeable improvement in 2024, markets perhaps have high expectations. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO